Apresentações

Predictive Markers of Gastroesophageal Tumors
Florian Lordick

Florian Lordick - GTG 2023 - Biomarker.pdf

Perioperative treatment for EGJ adenocarcinoma, Siewert II
Duílio Reis

Duilio Reis - GTG 2023.pdf

Immunotherapy in the Management of Gastroesophageal Tumors: when and to whom?
Erika Ruiz-Garcia

Erika Ruiz-Garcia - GTG 2023.pdf

Tratamento local na doença oligometastática em tumores esofagogástricos: qual a evidência?
Gustavo Fernandes

Gustavo Fernandes - GTG 2023.pdf

Real-life situations: Metastatic Gastric Cancer
Victor Hugo

Victor Hugo - GTG 2023.pdf

Third and Further Lines in Gastroesophageal Cancer and new Horizons
Paola Montenegro

Paola Montenegro - GTG 2023.pdf

Applicability of Liquid Biopsy in Non-Colon GI: Where are We?
Florian Lordick

Florian Lordick - GTG 2023 - Liquid Biopsy.pdf

Situação de vida real: Qual a melhor estratégia de tratamento em HCC?
Leonardo Fonseca

Leonardo Fonseca - GTG 2023.pdf

Does the etiology of the liver disease impact treatment choices in HCC?
Diogo Bugano

Diogo Bugano - GTG 2023.pdf

BCLC B: qual a melhor escolha? Quando indicar terapia local ou sistêmica?
Fabio Marinho

Fabio Marinho - GTG 2023.pdf

Real Life Situations: Management of Metastatic Bile Duct Tumor
Sebastian Mondaca

Sebastian Mondaca - GTG 2023.pdf

Pancreatic Cancer: Challenging Neoadjuvant for Resectable and Borderline Resectable Tumors
Mariano Dioca

Mariano Dioca - GTG 2023.pdf

Precision Medicine in Pancreatic Cancer: Proven and Novel Therapeutic Targets and Treatments
Michael Pishvaian

Michael Pishvaian - GTG 2023.pdf

Clinical case: HRD and PALB2, how to choose first-line? When to recommend maintenance?
Maria Ignez Braghiroli

Maria Ignez Braghiroli - GTG 2023.pdf

Real Life Situations: Management of G3 NET
Juliana Florinda

Juliana Florinda - GTG 2023.pdf

BRAF: for whom, when, how
Anelisa Coutinho

Anelisa Coutinho - GTG 2023.pdf

Spotlight on the new era of targeted therapy in BRAF V600E mutated metastatic CRC
Scott Kopetz

Scott Kopetz - GTG 2023 - Pfizer Symposium.pdf

Impacto da imagem nas decisões de manejo no câncer de reto
Cinthia Ortega

Cinthia Ortega - GTG 2023.pdf

TNT, How to Choose Among Current Regimens?
Juan O'Connor

Juan O Connor - GTG 2023.pdf

Clinical Case Discussion: Rectal Cancer
Fernanda Capareli

Fernanda Capareli - GTG 2023.pdf

Atualização sobre desenho e status do estudo brasileiro CCHOWW : "QTRT e QT consolidação com ou sem Oxaliplatina para câncer de reto distal e Watch and wait"
Bruna Vailati

Bruna Vailati - GTG 2023.pdf

Updates in DPD Deficiency
Celso Abdon

Celso Abdon - GTG 2023.pdf

Real Life Management: Not advanced Colorectal cancer
Marcela Crosara

Marcela Crosara - GTG 2023.pdf

Applicability of ctDNA in CRC
Scott Kopetz

Scott Kopetz - GTG 2023 - ctDNA.pdf

Immunotherapy in CRC: Ready for Primetime and More to Come
Heinz Josef Lenz

Heinz Josef Lenz - GTG 2023 - Immunotherapy in CRC.pdf

BRAF-mutant metastatic CRC: What is the best treatment?
Scott Kopetz

Scott Kopetz - GTG 2023 - Update on BRAF targeting.pdf

Targeting Ras mutations in CRC
Heinz Josef Lenz

Heinz Josef Lenz - GTG 2023 - Targeting Ras mutations in CRC.pdf

Situações de vida real Metastatic CCR Second-Line Treatment
Tiago Felismino

Tiago Felismino - GTG 2023.pdf

Treatment sequencing in unresectable metastatic colorectal cancer: ideal and real scenarios
Renata D'Alpino

Renata D Alpino - GTG 2023.pdf

Aulas

4º Simpósio Internacional GTG